| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 8.40e-10 | 4 | 109 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 8.40e-10 | 4 | 109 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 8.40e-10 | 4 | 109 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 4.18e-09 | 5 | 109 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 4.18e-09 | 5 | 109 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 4.18e-09 | 5 | 109 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 4.18e-09 | 5 | 109 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 4.18e-09 | 5 | 109 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 4.18e-09 | 5 | 109 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 4.18e-09 | 5 | 109 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.25e-08 | 6 | 109 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.90e-08 | 7 | 109 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 5.78e-08 | 8 | 109 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 5.78e-08 | 8 | 109 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 5.78e-08 | 8 | 109 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.04e-07 | 9 | 109 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.04e-07 | 9 | 109 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.72e-07 | 10 | 109 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.72e-07 | 10 | 109 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 8.06e-07 | 14 | 109 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.06e-07 | 14 | 109 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 3.81e-06 | 20 | 109 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 8.21e-06 | 24 | 109 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.14e-05 | 26 | 109 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.14e-05 | 26 | 109 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.34e-05 | 27 | 109 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.90e-05 | 60 | 109 | 5 | GO:0016655 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.06e-05 | 30 | 109 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 2.53e-05 | 11 | 109 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.69e-05 | 32 | 109 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.04e-05 | 33 | 109 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 3.43e-05 | 34 | 109 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 4.35e-05 | 13 | 109 | 3 | GO:0004535 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 5.96e-05 | 39 | 109 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 6.60e-05 | 40 | 109 | 4 | GO:0016896 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 6.60e-05 | 40 | 109 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | collagen binding | 8.14e-05 | 81 | 109 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.05e-04 | 45 | 109 | 4 | GO:0004532 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.36e-04 | 48 | 109 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.73e-04 | 95 | 109 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.76e-04 | 4 | 109 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.48e-04 | 56 | 109 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.67e-04 | 62 | 109 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.67e-04 | 62 | 109 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.67e-04 | 62 | 109 | 4 | GO:0016796 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.04e-03 | 9 | 109 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 1.07e-03 | 37 | 109 | 3 | GO:0000175 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.62e-03 | 92 | 109 | 4 | GO:0004527 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.66e-03 | 156 | 109 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | Roundabout binding | 1.88e-03 | 12 | 109 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.00e-03 | 239 | 109 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.72e-03 | 254 | 109 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.82e-03 | 107 | 109 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.65e-03 | 115 | 109 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 4.53e-03 | 61 | 109 | 3 | GO:0008408 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 4.75e-03 | 19 | 109 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.19e-03 | 127 | 109 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | steroid binding | 6.11e-03 | 133 | 109 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.60e-03 | 136 | 109 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.94e-03 | 138 | 109 | 4 | GO:0016614 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 7.38e-10 | 4 | 109 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 7.38e-10 | 4 | 109 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 7.38e-10 | 4 | 109 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 7.38e-10 | 4 | 109 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 3.67e-09 | 5 | 109 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 3.67e-09 | 5 | 109 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 3.67e-09 | 5 | 109 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 3.67e-09 | 5 | 109 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 3.67e-09 | 5 | 109 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 3.67e-09 | 5 | 109 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.10e-08 | 6 | 109 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.10e-08 | 6 | 109 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.55e-08 | 7 | 109 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.55e-08 | 7 | 109 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.55e-08 | 7 | 109 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.15e-08 | 21 | 109 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 7.15e-08 | 21 | 109 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 9.11e-08 | 9 | 109 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | parturition | 9.21e-08 | 22 | 109 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.51e-07 | 10 | 109 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.51e-07 | 10 | 109 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.51e-07 | 10 | 109 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.51e-07 | 10 | 109 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.51e-07 | 10 | 109 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 2.37e-07 | 11 | 109 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 2.37e-07 | 11 | 109 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 7.09e-07 | 14 | 109 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 7.09e-07 | 14 | 109 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 9.63e-07 | 15 | 109 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.28e-06 | 16 | 109 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.28e-06 | 16 | 109 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.64e-06 | 38 | 109 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | neuron development | ADCY10 MYH10 B4GAT1 MAP1A NRTN RTN4R ITGA3 WDPCP NCDN TSKU MET NTNG2 IGFALS HMCN2 UBE3A CSPG4 PAK1 SLITRK5 LRP2 DIO3 KCNQ2 GPC2 ULK2 | 1.92e-06 | 1463 | 109 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 MYH10 B4GAT1 MAP1A RTN4R WDPCP TSKU MET NTNG2 IGFALS HMCN2 UBE3A PAK1 SLITRK5 LRP2 ULK2 | 1.96e-06 | 748 | 109 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 2.13e-06 | 18 | 109 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic mRNA processing body assembly | 2.84e-06 | 6 | 109 | 3 | GO:0010606 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 4.12e-06 | 21 | 109 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 4.12e-06 | 21 | 109 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 4.12e-06 | 21 | 109 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 5.02e-06 | 22 | 109 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 5.02e-06 | 22 | 109 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 5.02e-06 | 22 | 109 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 6.05e-06 | 23 | 109 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 6.05e-06 | 23 | 109 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 7.23e-06 | 88 | 109 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic mRNA processing body assembly | 7.89e-06 | 8 | 109 | 3 | GO:0010603 | |
| GeneOntologyBiologicalProcess | axonogenesis | ADCY10 MYH10 B4GAT1 MAP1A RTN4R TSKU NTNG2 IGFALS HMCN2 PAK1 SLITRK5 LRP2 ULK2 | 9.18e-06 | 566 | 109 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.01e-05 | 26 | 109 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 1.05e-05 | 142 | 109 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.16e-05 | 56 | 109 | 5 | GO:0006693 | |
| GeneOntologyBiologicalProcess | neuron projection development | ADCY10 MYH10 B4GAT1 MAP1A NRTN RTN4R ITGA3 NCDN TSKU MET NTNG2 IGFALS HMCN2 UBE3A CSPG4 PAK1 SLITRK5 LRP2 GPC2 ULK2 | 1.17e-05 | 1285 | 109 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.26e-05 | 57 | 109 | 5 | GO:0006692 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.37e-05 | 28 | 109 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.58e-05 | 29 | 109 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.58e-05 | 29 | 109 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 MYH10 B4GAT1 MAP1A RTN4R TSKU MET NTNG2 IGFALS HMCN2 UBE3A PAK1 SLITRK5 LRP2 ULK2 | 2.08e-05 | 802 | 109 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 2.37e-05 | 32 | 109 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ADCY10 MYH10 B4GAT1 MAP1A RTN4R TSKU MET NTNG2 IGFALS HMCN2 UBE3A PAK1 SLITRK5 LRP2 ULK2 | 2.65e-05 | 819 | 109 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.68e-05 | 33 | 109 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ADCY10 MYH10 B4GAT1 MAP1A RTN4R TSKU MET NTNG2 IGFALS HMCN2 UBE3A PAK1 SLITRK5 LRP2 ULK2 | 2.93e-05 | 826 | 109 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.03e-05 | 34 | 109 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 3.41e-05 | 35 | 109 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | axon development | ADCY10 MYH10 B4GAT1 MAP1A RTN4R TSKU NTNG2 IGFALS HMCN2 PAK1 SLITRK5 LRP2 ULK2 | 3.44e-05 | 642 | 109 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | response to prostaglandin | 3.82e-05 | 36 | 109 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 3.82e-05 | 36 | 109 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.24e-05 | 73 | 109 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.82e-05 | 40 | 109 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 6.10e-05 | 128 | 109 | 6 | GO:0033559 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 7.08e-05 | 42 | 109 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 7.55e-05 | 133 | 109 | 6 | GO:0006766 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 9.30e-05 | 45 | 109 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 9.98e-05 | 202 | 109 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.10e-04 | 89 | 109 | 5 | GO:2000379 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.10e-04 | 89 | 109 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.10e-04 | 47 | 109 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.42e-04 | 94 | 109 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 1.49e-04 | 95 | 109 | 5 | GO:0006081 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | MYO1C LRRC24 ASIC1 RTN4R IKZF1 STIL WDPCP CNOT6 MET NTNG2 CNOT6L SSH3 VPS35 TBC1D12 PAK1 SLITRK5 CNOT1 | 1.63e-04 | 1189 | 109 | 17 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 MYH10 B4GAT1 MAP1A RTN4R IDUA WDPCP TSKU MET NTNG2 IGFALS HMCN2 UBE3A PAK1 SLITRK5 LRP2 ULK2 | 1.71e-04 | 1194 | 109 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.15e-04 | 161 | 109 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 2.35e-04 | 57 | 109 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | P-body assembly | 2.35e-04 | 23 | 109 | 3 | GO:0033962 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.38e-04 | 309 | 109 | 8 | GO:1901888 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.39e-04 | 105 | 109 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 2.51e-04 | 58 | 109 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.59e-04 | 313 | 109 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | synapse organization | MYH10 FNTA LRRC24 ASIC1 RTN4R ITGA3 NTNG2 HMCN2 UBE3A VPS35 PAK1 SLITRK5 | 2.70e-04 | 685 | 109 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.81e-04 | 239 | 109 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 2.87e-04 | 60 | 109 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 3.18e-04 | 244 | 109 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | head development | MYH10 IFT172 RTN4R IKZF1 STIL AK8 TSKU MET UBE3A PAK1 SLITRK5 ANKRD11 LRP2 KCNQ2 | 3.44e-04 | 919 | 109 | 14 | GO:0060322 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.90e-04 | 65 | 109 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ADCY10 RTN4R ITGA3 TSKU MET NTNG2 UBE3A CSPG4 PAK1 GPC2 ULK2 | 3.97e-04 | 612 | 109 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.16e-04 | 336 | 109 | 8 | GO:0071560 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.38e-04 | 67 | 109 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.77e-04 | 343 | 109 | 8 | GO:0071559 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.90e-04 | 69 | 109 | 4 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ADCY10 RTN4R ITGA3 WDPCP TSKU MET NTNG2 UBE3A CSPG4 VPS35 PAK1 GPC2 ULK2 | 5.23e-04 | 846 | 109 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | MYO1C FNTA ADAMTS3 LRRC32 AKR1C4 ITGA3 AKR1C1 AKR1C2 RYR1 MYOF UBE3A LRP2 AKR1C3 | 5.47e-04 | 850 | 109 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | neuron projection organization | 5.73e-04 | 127 | 109 | 5 | GO:0106027 | |
| GeneOntologyCellularComponent | CCR4-NOT complex | 7.15e-05 | 16 | 108 | 3 | GO:0030014 | |
| MousePheno | parturition failure | 3.58e-07 | 10 | 92 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 5.60e-07 | 11 | 92 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 1.20e-06 | 13 | 92 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 2.27e-06 | 15 | 92 | 4 | MP:0005186 | |
| MousePheno | long stride length | 2.27e-06 | 15 | 92 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 2.27e-06 | 15 | 92 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 5.01e-06 | 18 | 92 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 7.85e-06 | 20 | 92 | 4 | MP:0013438 | |
| MousePheno | decreased oligodendrocyte number | 2.00e-05 | 25 | 92 | 4 | MP:0009808 | |
| MousePheno | prolonged diestrus | 4.22e-05 | 30 | 92 | 4 | MP:0009011 | |
| MousePheno | abnormal parturition | 6.21e-05 | 33 | 92 | 4 | MP:0002907 | |
| MousePheno | abnormal diestrus | 7.87e-05 | 35 | 92 | 4 | MP:0009010 | |
| MousePheno | enhanced coordination | 1.09e-04 | 38 | 92 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 1.21e-04 | 39 | 92 | 4 | MP:0009006 | |
| MousePheno | decreased vocalization | 2.32e-04 | 46 | 92 | 4 | MP:0020351 | |
| MousePheno | abnormal muscle development | 2.67e-04 | 87 | 92 | 5 | MP:0000733 | |
| MousePheno | abnormal circulating progesterone level | 3.21e-04 | 50 | 92 | 4 | MP:0005184 | |
| MousePheno | abnormal oligodendrocyte morphology | 3.47e-04 | 51 | 92 | 4 | MP:0000953 | |
| MousePheno | increased stereotypic behavior | 4.02e-04 | 53 | 92 | 4 | MP:0001409 | |
| MousePheno | abnormal progesterone level | 4.32e-04 | 54 | 92 | 4 | MP:0011384 | |
| MousePheno | abnormal mitochondrial shape | 4.44e-04 | 23 | 92 | 3 | MP:0011633 | |
| Domain | LRR_8 | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 5.20e-08 | 171 | 107 | 10 | PF13855 |
| Domain | Leu-rich_rpt_typical-subtyp | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 7.20e-08 | 177 | 107 | 10 | IPR003591 |
| Domain | LRR_TYP | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 7.20e-08 | 177 | 107 | 10 | SM00369 |
| Domain | ALDOKETO_REDUCTASE_1 | 2.08e-07 | 10 | 107 | 4 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 2.08e-07 | 10 | 107 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.08e-07 | 10 | 107 | 4 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.08e-07 | 10 | 107 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.08e-07 | 10 | 107 | 4 | PS00063 | |
| Domain | LRR | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 2.37e-07 | 201 | 107 | 10 | PS51450 |
| Domain | LRR_1 | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 5.22e-07 | 219 | 107 | 10 | PF00560 |
| Domain | LRRNT | 1.50e-06 | 98 | 107 | 7 | IPR000372 | |
| Domain | LRRNT | 1.50e-06 | 98 | 107 | 7 | SM00013 | |
| Domain | - | 1.76e-06 | 16 | 107 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 2.29e-06 | 17 | 107 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 2.29e-06 | 17 | 107 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.29e-06 | 17 | 107 | 4 | IPR001395 | |
| Domain | - | NLRP7 LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 2.33e-06 | 321 | 107 | 11 | 3.80.10.10 |
| Domain | L_dom-like | NLRP7 LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 2.86e-06 | 328 | 107 | 11 | IPR032675 |
| Domain | Leu-rich_rpt | LRRC24 RTN4R LRRC32 LRCH1 CNOT6 TSKU IGFALS CNOT6L SLITRK5 LRRC15 | 3.57e-06 | 271 | 107 | 10 | IPR001611 |
| Domain | Cys-rich_flank_reg_C | 1.68e-04 | 90 | 107 | 5 | IPR000483 | |
| Domain | LRRCT | 1.68e-04 | 90 | 107 | 5 | SM00082 | |
| Domain | DUF3669_Znf | 4.80e-04 | 6 | 107 | 2 | IPR022137 | |
| Domain | DUF3669 | 4.80e-04 | 6 | 107 | 2 | PF12417 | |
| Domain | TIL_dom | 2.83e-03 | 14 | 107 | 2 | IPR002919 | |
| Domain | ARM-type_fold | 3.38e-03 | 339 | 107 | 7 | IPR016024 | |
| Domain | LRRNT | 3.48e-03 | 53 | 107 | 3 | PF01462 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.02e-07 | 9 | 77 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.02e-07 | 9 | 77 | 4 | M47817 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.50e-07 | 45 | 77 | 6 | MM15344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.64e-07 | 11 | 77 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.67e-07 | 13 | 77 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.67e-07 | 13 | 77 | 4 | MM14747 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.64e-07 | 92 | 77 | 7 | MM14881 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 7.90e-07 | 14 | 77 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 7.90e-07 | 14 | 77 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 7.90e-07 | 14 | 77 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 7.90e-07 | 14 | 77 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.07e-06 | 15 | 77 | 4 | MM14870 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 6.08e-06 | 48 | 77 | 5 | M27642 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.73e-06 | 23 | 77 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.73e-06 | 23 | 77 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.73e-06 | 23 | 77 | 4 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.53e-05 | 28 | 77 | 4 | MM15188 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.73e-05 | 100 | 77 | 6 | M27158 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.00e-05 | 61 | 77 | 5 | MM14861 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.99e-05 | 33 | 77 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.99e-05 | 33 | 77 | 4 | MM14737 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 7.59e-05 | 189 | 77 | 7 | MM14772 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 7.85e-05 | 190 | 77 | 7 | MM15687 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 9.46e-05 | 44 | 77 | 4 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.03e-04 | 45 | 77 | 4 | MM14751 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.21e-04 | 18 | 77 | 3 | MM15336 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.45e-04 | 49 | 77 | 4 | MM15186 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.94e-04 | 21 | 77 | 3 | M27634 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 2.12e-04 | 54 | 77 | 4 | MM15089 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.27e-04 | 55 | 77 | 4 | M14933 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 2.44e-04 | 56 | 77 | 4 | M839 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.92e-04 | 24 | 77 | 3 | MM15090 | |
| Pathway | KEGG_RNA_DEGRADATION | 2.98e-04 | 59 | 77 | 4 | M963 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 3.31e-04 | 25 | 77 | 3 | M13492 | |
| Pathway | REACTOME_DRUG_ADME | 4.79e-04 | 119 | 77 | 5 | MM15692 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.74e-04 | 70 | 77 | 4 | M16794 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 7.37e-04 | 198 | 77 | 6 | M18311 | |
| Pathway | REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS | 7.60e-04 | 33 | 77 | 3 | M48026 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 8.30e-04 | 34 | 77 | 3 | MM15325 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.10e-03 | 143 | 77 | 5 | M27275 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.53e-03 | 154 | 77 | 5 | M27832 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 1.57e-03 | 11 | 77 | 2 | M39749 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.89e-03 | 45 | 77 | 3 | M39355 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 2.21e-03 | 13 | 77 | 2 | MM14805 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 2.27e-03 | 48 | 77 | 3 | MM14696 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 2.36e-03 | 170 | 77 | 5 | MM15573 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 2.41e-03 | 49 | 77 | 3 | M27614 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.43e-03 | 250 | 77 | 6 | M27554 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 2.55e-03 | 50 | 77 | 3 | M678 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 2.57e-03 | 14 | 77 | 2 | M651 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 9.47e-11 | 4 | 110 | 4 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 9.47e-11 | 4 | 110 | 4 | 16508162 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 9.47e-11 | 4 | 110 | 4 | 14967952 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 9.47e-11 | 4 | 110 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 9.47e-11 | 4 | 110 | 4 | 31479646 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 15222881 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 16191478 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 15577209 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 10702227 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 17034817 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 9.47e-11 | 4 | 110 | 4 | 29764944 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 10526179 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 17888864 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 17442338 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 28329705 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 16018803 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 17272929 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 9.47e-11 | 4 | 110 | 4 | 18667791 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 28259989 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 21521174 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 8274401 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 16511129 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 9.47e-11 | 4 | 110 | 4 | 34590152 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 7789999 | ||
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 4.72e-10 | 5 | 110 | 4 | 21851338 | |
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 4.72e-10 | 5 | 110 | 4 | 17064890 | |
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 10672042 | ||
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 4.72e-10 | 5 | 110 | 4 | 16984997 | |
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 18003893 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.41e-09 | 6 | 110 | 4 | 29107092 | |
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 19273550 | ||
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 15860270 | ||
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.41e-09 | 6 | 110 | 4 | 26748576 | |
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.41e-09 | 6 | 110 | 4 | 17255200 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RTL6 LRRC24 ITGA3 IDUA RYR1 GRAMD2A MYOF URB1 PLA2G4B SURF6 CSPG4 DUSP16 ANKRD11 ZNF398 CPSF1 KCNQ2 GPC2 SNAPC4 ULK2 | 1.86e-09 | 1105 | 110 | 19 | 35748872 |
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 3.29e-09 | 7 | 110 | 4 | 34843575 | |
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 22529366 | ||
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 33127481 | ||
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 12562828 | ||
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 16337335 | ||
| Pubmed | 6.57e-09 | 8 | 110 | 4 | 33584538 | ||
| Pubmed | 6.57e-09 | 8 | 110 | 4 | 20837989 | ||
| Pubmed | 6.57e-09 | 8 | 110 | 4 | 9224647 | ||
| Pubmed | 1.18e-08 | 9 | 110 | 4 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.96e-08 | 10 | 110 | 4 | 36313771 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 3.08e-08 | 3 | 110 | 3 | 31780644 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 7626489 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 21232532 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 13678667 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 4.60e-08 | 12 | 110 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 4.60e-08 | 12 | 110 | 4 | 28893949 | |
| Pubmed | 4.60e-08 | 12 | 110 | 4 | 25774556 | ||
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 11682476 | ||
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 6.63e-08 | 13 | 110 | 4 | 15117747 | |
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 24580729 | ||
| Pubmed | 9.25e-08 | 14 | 110 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 9.25e-08 | 14 | 110 | 4 | 34400844 | |
| Pubmed | 2.18e-07 | 17 | 110 | 4 | 32243503 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 22977175 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 15212687 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 3.54e-07 | 19 | 110 | 4 | 17599069 | |
| Pubmed | 3.98e-07 | 47 | 110 | 5 | 11208732 | ||
| Pubmed | 4.41e-07 | 20 | 110 | 4 | 23636947 | ||
| Pubmed | 4.41e-07 | 20 | 110 | 4 | 24135228 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 31924127 | ||
| Pubmed | 8.01e-07 | 23 | 110 | 4 | 23685333 | ||
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 19846565 | ||
| Pubmed | 1.14e-06 | 25 | 110 | 4 | 26098214 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 1.34e-06 | 26 | 110 | 4 | 23892084 | |
| Pubmed | 1.57e-06 | 27 | 110 | 4 | 17077188 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 1.57e-06 | 27 | 110 | 4 | 14581517 | |
| Pubmed | 1.57e-06 | 27 | 110 | 4 | 23471215 | ||
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 1.83e-06 | 28 | 110 | 4 | 29879378 | |
| Pubmed | 1.83e-06 | 28 | 110 | 4 | 21820362 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 1.83e-06 | 28 | 110 | 4 | 29212953 | |
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 21741365 | ||
| Pubmed | 2.62e-06 | 122 | 110 | 6 | 30773093 | ||
| Pubmed | 3.18e-06 | 32 | 110 | 4 | 34288113 | ||
| Pubmed | 3.63e-06 | 10 | 110 | 3 | 27618784 | ||
| Pubmed | 5.77e-06 | 37 | 110 | 4 | 21362171 | ||
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 17452450 | ||
| Pubmed | Human Ccr4-Not complexes contain variable deadenylase subunits. | 6.63e-06 | 12 | 110 | 3 | 19558367 | |
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 31320642 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 B4GAT1 MYO1C RTN4R AKR1C4 IDUA AKR1C1 MYOF IGFALS KRT77 CSPG4 LRP2 AKR1C3 LRRC15 | 7.39e-06 | 1070 | 110 | 14 | 23533145 |
| Pubmed | WAPL AKR1C4 AKR1C1 AKR1C2 NCDN GRAMD2A URB1 CNOT6L VPS33B AMOT LRP2 AKR1C3 ULK2 CNOT1 | 8.56e-06 | 1084 | 110 | 14 | 11544199 | |
| Pubmed | NANOS2 interacts with the CCR4-NOT deadenylation complex and leads to suppression of specific RNAs. | 8.60e-06 | 13 | 110 | 3 | 20133598 | |
| Interaction | AKR1C4 interactions | 5.17e-08 | 8 | 107 | 4 | int:AKR1C4 | |
| Interaction | TOP3B interactions | MYH10 RTL6 MYO1C LRRC24 ITGA3 IDUA RYR1 GRAMD2A MYOF URB1 CNOT6L PLA2G4B SURF6 CSPG4 DUSP16 ANKRD11 ZNF398 CPSF1 KCNQ2 GPC2 SNAPC4 ULK2 CNOT1 | 2.20e-06 | 1470 | 107 | 23 | int:TOP3B |
| Interaction | NANOS1 interactions | 3.41e-06 | 20 | 107 | 4 | int:NANOS1 | |
| Interaction | AKR1C1 interactions | 3.41e-06 | 20 | 107 | 4 | int:AKR1C1 | |
| Interaction | N4BP2 interactions | 7.91e-06 | 89 | 107 | 6 | int:N4BP2 | |
| Interaction | AKR1C3 interactions | 4.33e-05 | 37 | 107 | 4 | int:AKR1C3 | |
| Cytoband | 10p15-p14 | 2.66e-07 | 6 | 110 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 6.80e-05 | 90 | 110 | 4 | chr10p15 | |
| Cytoband | 7q36.1 | 7.67e-04 | 74 | 110 | 3 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.15e-03 | 325 | 110 | 5 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.28e-03 | 195 | 110 | 4 | chr10q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.69e-03 | 355 | 110 | 5 | chr8q24 | |
| GeneFamily | Aldo-keto reductases | 2.72e-07 | 15 | 70 | 4 | 399 | |
| GeneFamily | CCR4-NOT transcription complex | 8.97e-06 | 11 | 70 | 3 | 1023 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 6.46e-07 | 17 | 109 | 4 | MM826 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 1.21e-06 | 45 | 109 | 5 | MM1173 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | 1.96e-06 | 200 | 109 | 8 | M9842 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 2.82e-06 | 24 | 109 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 3.35e-06 | 25 | 109 | 4 | MM480 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 7.13e-06 | 30 | 109 | 4 | MM853 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.45e-05 | 74 | 109 | 5 | MM769 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.50e-05 | 36 | 109 | 4 | MM3660 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 1.61e-05 | 192 | 109 | 7 | M4277 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 1.68e-05 | 37 | 109 | 4 | MM630 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 2.00e-05 | 79 | 109 | 5 | MM535 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | BCL3 RAD54L2 IDUA NDUFB4 CES2 DPEP2 PLA2G4B SSH3 ANKRD11 CPSF1 CACNA1I | 6.84e-05 | 634 | 109 | 11 | M40866 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 6.85e-05 | 102 | 109 | 5 | MM872 | |
| Coexpression | MARCHINI_TRABECTEDIN_RESISTANCE_UP | 7.57e-05 | 20 | 109 | 3 | M17330 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 9.03e-05 | 174 | 109 | 6 | MM836 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.02e-04 | 111 | 109 | 5 | MM705 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 1.15e-04 | 60 | 109 | 4 | MM847 | |
| Coexpression | BAKKER_FOXO3_TARGETS_DN | 1.38e-04 | 188 | 109 | 6 | MM904 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.50e-04 | 191 | 109 | 6 | MM17059 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.67e-04 | 66 | 109 | 4 | MM631 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.73e-04 | 196 | 109 | 6 | M3008 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.88e-04 | 199 | 109 | 6 | M7259 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 1.93e-04 | 200 | 109 | 6 | M6640 | |
| Coexpression | GSE42724_NAIVE_VS_MEMORY_BCELL_DN | 1.93e-04 | 200 | 109 | 6 | M9793 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.99e-04 | 69 | 109 | 4 | MM621 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 2.29e-04 | 293 | 109 | 7 | MM895 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF NTNG2 CSPG4 DIO3 TLE6 ARHGAP20 ULK2 CCDC33 | 6.52e-07 | 462 | 108 | 13 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#3 | RIPOR3 IKZF1 BCL3 GRAMD2A MYOF KRT77 CSPG4 DIO3 TLE6 ARHGAP20 ULK2 CCDC33 | 1.51e-06 | 419 | 108 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF HMCN2 CSPG4 TLE6 ARHGAP20 ULK2 CCDC33 | 2.12e-06 | 433 | 108 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 DIO3 TLE6 GPC2 ARHGAP20 ULK2 CCDC33 | 2.92e-06 | 529 | 108 | 13 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 DIO3 TLE6 GPC2 ARHGAP20 ULK2 CCDC33 | 2.98e-06 | 530 | 108 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 TLE6 ARHGAP20 ULK2 CCDC33 | 4.11e-06 | 383 | 108 | 11 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 DIO3 TLE6 ARHGAP20 ULK2 CCDC33 | 4.21e-06 | 463 | 108 | 12 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#3 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 TLE6 ARHGAP20 ULK2 CCDC33 | 7.84e-06 | 410 | 108 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 TLE6 ARHGAP20 ULK2 CCDC33 | 9.83e-06 | 420 | 108 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 DIO3 TLE6 ARHGAP20 ULK2 CCDC33 | 1.07e-05 | 508 | 108 | 12 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | LRRC24 IKZF1 BCL3 GRAMD2A MYOF NTNG2 HMCN2 KRT77 CSPG4 TLE6 ARHGAP20 ULK2 CCDC33 | 1.50e-05 | 616 | 108 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RIPOR3 IKZF1 BCL3 GRAMD2A MYOF CSPG4 DIO3 TLE6 ARHGAP20 ULK2 CCDC33 | 1.75e-05 | 447 | 108 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RIPOR3 IKZF1 BCL3 GRAMD2A MYOF NTNG2 CSPG4 DIO3 TLE6 ARHGAP20 ULK2 | 2.15e-05 | 457 | 108 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.51e-05 | 196 | 108 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.72e-05 | 197 | 108 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.17e-05 | 207 | 108 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.16e-04 | 215 | 108 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | LRRC24 RIPOR3 IKZF1 BCL3 METTL21EP GRAMD2A MYOF CSPG4 DIO3 TLE6 GPC2 ARHGAP20 ULK2 CCDC33 | 1.45e-04 | 878 | 108 | 14 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.70e-04 | 433 | 108 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | MYH10 WAPL IKZF1 BCL3 STIL GRAMD2A NTNG2 CNOT6L HMCN2 TTC7B KRT77 TLE6 ULK2 CCDC33 | 4.41e-04 | 979 | 108 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.30e-04 | 276 | 108 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 6.49e-06 | 184 | 110 | 6 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 6.49e-06 | 184 | 110 | 6 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.31e-06 | 196 | 110 | 6 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 9.58e-06 | 197 | 110 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-06 | 198 | 110 | 6 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| Drug | cloxazolam | 4.97e-10 | 4 | 109 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 4.97e-10 | 4 | 109 | 4 | ctd:D011278 | |
| Drug | tetralol | 4.97e-10 | 4 | 109 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 4.97e-10 | 4 | 109 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 2.48e-09 | 5 | 109 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 2.48e-09 | 5 | 109 | 4 | ctd:C010092 | |
| Drug | Medazepam | 7.40e-09 | 6 | 109 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 3.43e-08 | 8 | 109 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 6.15e-08 | 9 | 109 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 6.15e-08 | 9 | 109 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 1.02e-07 | 10 | 109 | 4 | ctd:C016627 | |
| Drug | cyclopentanol | 1.07e-07 | 3 | 109 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.07e-07 | 3 | 109 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.07e-07 | 3 | 109 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.07e-07 | 3 | 109 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.07e-07 | 3 | 109 | 3 | ctd:C530610 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.60e-07 | 11 | 109 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.60e-07 | 11 | 109 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 2.39e-07 | 12 | 109 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 3.44e-07 | 13 | 109 | 4 | CID000050096 | |
| Drug | flunisolide | 3.44e-07 | 13 | 109 | 4 | ctd:C007734 | |
| Drug | tetrahydrodeoxycorticosterone | 4.25e-07 | 4 | 109 | 3 | ctd:C009413 | |
| Drug | gliquidone | 4.25e-07 | 4 | 109 | 3 | ctd:C010969 | |
| Drug | DBD-H | 4.25e-07 | 4 | 109 | 3 | CID000131382 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.39e-07 | 196 | 109 | 9 | 3837_UP | |
| Drug | 5-alpha-Dihydroprogesterone | 4.79e-07 | 14 | 109 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 4.79e-07 | 14 | 109 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 4.79e-07 | 14 | 109 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 1.06e-06 | 5 | 109 | 3 | CID000257630 | |
| Drug | oxcarbazepine | 1.82e-06 | 19 | 109 | 4 | ctd:C036006 | |
| Drug | AC1L93E5 | 2.11e-06 | 6 | 109 | 3 | CID000412383 | |
| Drug | Estazolam | 2.11e-06 | 6 | 109 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 2.11e-06 | 6 | 109 | 3 | CID000439898 | |
| Drug | Glipizide | 2.11e-06 | 6 | 109 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 2.11e-06 | 6 | 109 | 3 | ctd:C023723 | |
| Drug | benzo(a)pyrene-7,8-dione | 2.27e-06 | 20 | 109 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 2.27e-06 | 20 | 109 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 2.79e-06 | 21 | 109 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 3.40e-06 | 22 | 109 | 4 | CID000000418 | |
| Drug | 4-hydroxyequilenin-o-quinone | 3.68e-06 | 7 | 109 | 3 | ctd:C117714 | |
| Drug | zomepirac | 3.68e-06 | 7 | 109 | 3 | ctd:C020549 | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; HL60; HT_HG-U133A | 4.22e-06 | 193 | 109 | 8 | 2346_UP | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.22e-06 | 193 | 109 | 8 | 4122_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.55e-06 | 195 | 109 | 8 | 2168_DN | |
| Drug | Glycyrrhetinic Acid | 4.91e-06 | 24 | 109 | 4 | ctd:D006034 | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; PC3; HT_HG-U133A | 5.09e-06 | 198 | 109 | 8 | 5095_UP | |
| Drug | 9,10-phenanthrenequinone | 5.82e-06 | 25 | 109 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 5.82e-06 | 25 | 109 | 4 | ctd:D011280 | |
| Drug | 2-cyclohexen-1-ol | 5.87e-06 | 8 | 109 | 3 | CID000013198 | |
| Drug | Hexestrol | 6.59e-06 | 55 | 109 | 5 | ctd:D006589 | |
| Drug | 1,2-dihydroxynaphthalene | 7.87e-06 | 57 | 109 | 5 | CID000011318 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.42e-05 | 31 | 109 | 4 | ctd:C017228 | |
| Drug | chlordecone | 1.75e-05 | 67 | 109 | 5 | CID000000299 | |
| Drug | alpha-methylcinnamic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.27e-05 | 2 | 109 | 2 | DB07768 | |
| Drug | baccharin | 2.27e-05 | 2 | 109 | 2 | ctd:C012764 | |
| Drug | fenamic acid | 2.28e-05 | 12 | 109 | 3 | ctd:C001209 | |
| Drug | estazolam | 2.32e-05 | 35 | 109 | 4 | CID000003261 | |
| Drug | 5 beta-pregnane-3,20-dione | 2.49e-05 | 72 | 109 | 5 | CID000092745 | |
| Drug | quercitrin | 2.60e-05 | 36 | 109 | 4 | CID005280459 | |
| Drug | 4-formyl-benzoate | 2.95e-05 | 13 | 109 | 3 | CID000012088 | |
| Drug | 5 alpha-androstane-3 beta,17 beta-diol | 3.09e-05 | 185 | 109 | 7 | CID000011301 | |
| Drug | Dydrogesterone | 3.74e-05 | 14 | 109 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 3.74e-05 | 14 | 109 | 3 | CID000631219 | |
| Drug | 20 alpha-dihydroprogesterone | 3.98e-05 | 40 | 109 | 4 | CID000008956 | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.05e-05 | 193 | 109 | 7 | 4286_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 4.05e-05 | 193 | 109 | 7 | 4670_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 3137_DN | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 3091_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 7468_UP | |
| Drug | o-quinone | 4.39e-05 | 41 | 109 | 4 | CID000011421 | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 5751_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 4644_UP | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 3359_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 4507_UP | |
| Drug | drospirenone | 4.66e-05 | 15 | 109 | 3 | ctd:C035144 | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 6354_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 4294_DN | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; HL60; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 6126_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 2348_UP | |
| Drug | 9-cis-retinal | 5.71e-05 | 16 | 109 | 3 | ctd:C031390 | |
| Drug | Flufenamic Acid | 6.37e-05 | 45 | 109 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 6.37e-05 | 45 | 109 | 4 | CID000000362 | |
| Drug | benzo(a)pyrene-1,6-quinone | 6.91e-05 | 17 | 109 | 3 | ctd:C030233 | |
| Drug | CQ-S | 6.91e-05 | 17 | 109 | 3 | CID000072462 | |
| Drug | cloxazolam | 8.27e-05 | 18 | 109 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 8.27e-05 | 18 | 109 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 8.27e-05 | 18 | 109 | 3 | ctd:C018003 | |
| Drug | AC1L8ZBW | 9.78e-05 | 19 | 109 | 3 | CID000435356 | |
| Drug | androstane-3,17-dione | 1.04e-04 | 51 | 109 | 4 | CID000000443 | |
| Drug | caffeic acid phenethyl ester | 1.27e-04 | 311 | 109 | 8 | ctd:C055494 | |
| Drug | 3-hydroxyandrostan-17-one | 1.32e-04 | 102 | 109 | 5 | CID000000225 | |
| Drug | coniferaldehyde | 1.33e-04 | 21 | 109 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 1.33e-04 | 21 | 109 | 3 | ctd:D000068538 | |
| Drug | flufenamic acid | 1.73e-04 | 108 | 109 | 5 | CID000003371 | |
| Drug | phenolphthalein | 1.73e-04 | 58 | 109 | 4 | CID000004764 | |
| Drug | NSC36919 | 1.73e-04 | 58 | 109 | 4 | CID000235496 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 1.76e-04 | 23 | 109 | 3 | DB03461 | |
| Drug | medazepam | 2.01e-04 | 24 | 109 | 3 | CID000004041 | |
| Drug | 9,10-phenanthrenequinone | 2.10e-04 | 61 | 109 | 4 | CID000006763 | |
| Disease | Neoplasms, Hormone-Dependent | 5.04e-08 | 3 | 110 | 3 | C0027661 | |
| Disease | Ambiguous Genitalia | 5.01e-07 | 5 | 110 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 5.01e-07 | 5 | 110 | 3 | C0033804 | |
| Disease | Hermaphroditism | 5.01e-07 | 5 | 110 | 3 | C0019269 | |
| Disease | Intersex Conditions | 5.01e-07 | 5 | 110 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 5.01e-07 | 5 | 110 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 1.75e-06 | 7 | 110 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 1.38e-05 | 2 | 110 | 2 | C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 1.38e-05 | 2 | 110 | 2 | 614279 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 1.38e-05 | 2 | 110 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 1.38e-05 | 2 | 110 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | cortolone glucuronide (1) measurement | 2.05e-04 | 6 | 110 | 2 | EFO_0800552 | |
| Disease | heart disease (implicated_via_orthology) | 3.87e-04 | 38 | 110 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.14e-04 | 93 | 110 | 4 | C1535926 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 6.08e-04 | 10 | 110 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | Metabolic Bone Disorder | 1.22e-03 | 14 | 110 | 2 | C0005944 | |
| Disease | unipolar depression, cognitive function measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | Osteopenia | 1.40e-03 | 15 | 110 | 2 | C0029453 | |
| Disease | response to methotrexate | 1.60e-03 | 16 | 110 | 2 | GO_0031427 | |
| Disease | Schizophrenia | 1.74e-03 | 883 | 110 | 10 | C0036341 | |
| Disease | Neoplastic Cell Transformation | 1.85e-03 | 139 | 110 | 4 | C0007621 | |
| Disease | free androgen index | 2.82e-03 | 374 | 110 | 6 | EFO_0007005 | |
| Disease | N-glycan measurement | 3.03e-03 | 22 | 110 | 2 | EFO_0004999 | |
| Disease | schizophrenia (is_implicated_in) | 3.13e-03 | 78 | 110 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Endometrioma | 3.15e-03 | 161 | 110 | 4 | C0269102 | |
| Disease | Endometriosis | 3.15e-03 | 161 | 110 | 4 | C0014175 | |
| Disease | Epilepsy, Cryptogenic | 3.60e-03 | 82 | 110 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.60e-03 | 82 | 110 | 3 | C0751111 | |
| Disease | Aura | 3.60e-03 | 82 | 110 | 3 | C0236018 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRQLLQRYLAAAGEQ | 66 | O60347 | |
| TPALIALRYQLQRGV | 251 | P17516 | |
| GPYQEARRQLSLLLD | 551 | Q8NCV1 | |
| QRLLQEQLRYGNPSE | 16 | Q4VCS5 | |
| RAGYPLSERQQVALL | 106 | Q6UB99 | |
| QLLLYRVVRGPQLGR | 1616 | Q6UVK1 | |
| GRYALRLSAENPLQV | 41 | Q8N5R6 | |
| SYPNNLLRNLAREGA | 206 | O43505 | |
| PGLDQLNRQLQLVTY | 211 | Q00973 | |
| TPALIALRYQLQRGV | 251 | P42330 | |
| QLLQRLYDPVQGQVL | 1061 | Q2M3G0 | |
| LRELVLAGNRLAYLQ | 196 | P35858 | |
| RINDQLARLYIIPGI | 166 | Q8IU60 | |
| RRVVLTGYPLQNNLI | 486 | Q9Y4B4 | |
| LLLNSRYPQLIQVLG | 1346 | Q96PN6 | |
| YLALPERAQLAAQLG | 141 | Q92988 | |
| LLQQLRELPGQLASY | 86 | Q9H3Z7 | |
| YQAIQKALRQRLGPE | 36 | P43351 | |
| NAYDIPRRGLLDQLT | 511 | Q5JSJ4 | |
| IARLAQYRALLQGAP | 51 | Q99748 | |
| NQGRYPLIQTLRQEL | 371 | Q13231 | |
| LNRLGIQAEPLYRVV | 166 | P78559 | |
| LNQAEGRNPTLERYL | 26 | Q9UBB6 | |
| LPRTLGELQLYRVLQ | 36 | Q15742 | |
| GELQLYRVLQRANLL | 41 | Q15742 | |
| RQVLGARGYSLNLIP | 36 | Q8N158 | |
| ILDYAQGNRPLVLNF | 151 | P55073 | |
| RLQQGAYRLLPSNAL | 3801 | Q8NDA2 | |
| NRQGELRISVLPAYL | 991 | Q10570 | |
| QAHLLNRLGYNPNRV | 361 | Q96MA6 | |
| QTERQQRYLLLAGAP | 61 | P26006 | |
| KLQNFLYNVLERPRG | 76 | O43526 | |
| QYLQLNLQPAVGRAL | 516 | O00748 | |
| LAQLRVLYLAGNQLA | 121 | Q50LG9 | |
| LNVRRNYLKVLPQEL | 216 | Q9Y2L9 | |
| LRIGKQPYRLQIQLS | 221 | Q96KN1 | |
| LGAYRPTRLQLEQLG | 401 | Q86UY5 | |
| VLRDNVPNLRGLQVY | 1996 | P98164 | |
| LPELLGNLQYNISRN | 146 | A6NDL7 | |
| LGVLAPSQLQRYRQE | 371 | P0C869 | |
| NNAINYLGAESLRPL | 316 | Q13422 | |
| LNLEQGRYLNPLQTD | 161 | Q9BSC4 | |
| IGANAQLRYRLNPNE | 161 | Q9Y5H7 | |
| EYLLQYNDPNRRGLI | 46 | O95168 | |
| ILTPLGRYQIINGLR | 706 | Q9NXE4 | |
| GLLLRAQRPGLALNY | 1221 | Q9UG01 | |
| LAALPRLIYLNLSNN | 261 | Q14392 | |
| RLIYLNLSNNLIRLP | 266 | Q14392 | |
| GRPLSQLLNLDLSYN | 311 | Q14392 | |
| NENPLRALYLIATNG | 466 | Q13153 | |
| RANLLLLGYAQGRLE | 261 | O95876 | |
| YQLRTVRCLQPLLDG | 926 | O15072 | |
| LYQALQSRRQALGPE | 456 | Q9P0X4 | |
| PARVGILLDYNNQRL | 4006 | Q8N3K9 | |
| RILPNLYLGCQRDVL | 161 | Q9BY84 | |
| IFRLYRAIGNIIPLQ | 261 | Q96DP5 | |
| GYLDLLRENQLLPGF | 116 | P35475 | |
| LRQAVRLNPDNGYIK | 206 | P09914 | |
| DLPLVLRQVYQKGLQ | 91 | Q9H4A9 | |
| LLPELRRASNLLYGQ | 486 | Q8IXB1 | |
| QRDFLLQGRLYISPN | 96 | Q8IUY3 | |
| GGRELDIYNNLRQTP | 161 | P20749 | |
| QDIDGRPLYILRLGQ | 321 | O43304 | |
| PGRELLLQTNLINYV | 626 | P21817 | |
| RAGLNEFIQNLVRYP | 91 | Q96BR1 | |
| ILNLYQEPDGTRRLL | 136 | Q9ULM6 | |
| IRALELDPNLYRIGQ | 751 | P35580 | |
| PGRQQVRDQGAYLIL | 301 | Q9BTY7 | |
| LLRPALGGTYVQREN | 256 | Q96CW9 | |
| DITVYLLQGRRLLQP | 1291 | P08581 | |
| QLPRANVVLLRYLFG | 476 | Q9P2F6 | |
| QPRSLLLQAARGYVV | 41 | P82914 | |
| PLRNNYQGFLAELRR | 161 | Q6ICC9 | |
| LAPLRALQYLRLNDN | 246 | Q9BZR6 | |
| RPHYLQLDLLQPRNL | 2121 | A2VEC9 | |
| LGNLQVLRLYENRLT | 196 | Q8TF66 | |
| QLRYELQGLPLLTQI | 181 | Q9NVN3 | |
| DRGLSKYPNLLNQLL | 286 | P49354 | |
| GRLLESLGQLYRNLN | 1001 | Q8TF17 | |
| LRDLQLLAQQPIYVR | 306 | Q8WX94 | |
| GNLTPLTGRNYRQLL | 226 | O75683 | |
| PILQNIGQLGLLARY | 1061 | O60287 | |
| SNYLIVLGSQRRRNP | 196 | O00764 | |
| NDQGQVRLRAGLPIY | 206 | O43463 | |
| ELRLGLPLQQYRDFI | 301 | Q8TE77 | |
| TPALIALRYQLQRGV | 251 | Q04828 | |
| TPALIALRYQLQRGV | 251 | P52895 | |
| AGELLALLNNRYEIP | 111 | P78348 | |
| NNLLRVLPYELGRLF | 111 | Q96LI5 | |
| PGNRYNLQLINALVL | 2206 | A5YKK6 | |
| YLLNQNLRSIPEQLG | 1151 | Q15468 | |
| GLYGRLLQIERFPQA | 141 | A0A0J9YY54 | |
| GQQLNPYLRLKVRRD | 516 | Q05086 | |
| QPQLRELEYQVLGFR | 531 | Q96MK2 | |
| LLLSGNLLNRLYPNE | 86 | O94991 | |
| QHPLRGLFLRNYLLQ | 141 | Q96QK1 | |
| YGLLQRRLENLENLL | 106 | Q8TD17 | |
| YLPQEQRFDIRVLGL | 971 | Q7Z5K2 | |
| YRQLALNAPGENILF | 61 | Q6UXR4 | |
| FLPSAQRALYLRIQQ | 761 | Q9UPT8 | |
| YKNPRNNLRSLLGER | 56 | Q08AG5 | |
| SPYLANLLLGLLQRN | 241 | Q8IYT8 | |
| IPEALGYVRQALQLQ | 531 | Q86TV6 | |
| VRGQLQDNPAYLLLR | 1351 | Q5SXM2 | |
| LQAEGILLPRYAILN | 141 | O43314 | |
| LELLERLQNGPIGQY | 96 | P36406 | |
| NLRDLPLRYLSLDGN | 201 | Q8WUA8 | |
| LARDQLIYLLEQLPG | 21 | Q9H267 | |
| YGLLQRRLENLENLL | 161 | Q9UDV7 | |
| LNYQGILNRLKQFPR | 31 | Q9H808 | |
| LEPLLENYIGDLRRQ | 211 | Q7Z794 | |
| TLRRLGLERNPQSYL | 251 | O00159 | |
| RIYIVRGLELQPQDN | 1556 | Q9NZM1 |